Unraveling the peculiarities and development of novel inhibitors of leishmanial arginyl‐tRNA synthetase
The FEBS Journal · 2024
DOI: 10.1111/febs.17122 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2024. Verfasst von Fouzia Nasim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology & Bioinformatics, School of Life Sciences, University of Hyderabad, Hyderabad, India. Hauptthemen laut MEDLINE: Leishmania donovani, Enzyme Inhibitors, Arginine-tRNA Ligase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: UoH-Institution of Eminence.
Abstract (Originalsprache)
Aminoacylation by tRNA synthetase is a crucial part of protein synthesis and is widely recognized as a therapeutic target for drug development. Unlike the arginyl‐tRNA synthetases (ArgRSs) reported previously, here, we report an ArgRS of Leishmania donovani ( Ld ArgRS) that can follow the canonical two‐step aminoacylation process. Since a previously uncharacterized insertion region is present within its catalytic domain, we implemented the splicing by overlap extension PCR (SOE–PCR) method to create a deletion mutant (ΔIns‐ Ld ArgRS) devoid of this region to investigate its function. Notably, the purified Ld ArgRS and ΔIns‐ Ld ArgRS exhibited different oligomeric states along with variations in their enzymatic activity. The full‐length protein showed better catalytic efficiency than ΔIns‐ Ld ArgRS, and the insertion region was identified as the tRNA binding domain. In addition, a benzothiazolo‐coumarin derivative (Comp‐7j) possessing high pharmacokinetic properties was recognized as a competitive and more specific inhibitor of Ld ArgRS than its human counterpart. Removal of the insertion region altered the mode of inhibition for ΔIns‐ Ld ArgRS and caused a reduction in the inhibitor's binding affinity. Both purified proteins depicted variances in the secondary structural content upon ligand binding and thus, thermostability. Apart from the trypanosomatid‐specific insertion and Rossmann fold motif, Ld ArgRS revealed typical structural characteristics of ArgRSs, and Comp‐7j was found to bind within the ATP binding pocket. Furthermore, the placement of tRNA Arg near the insertion region enhanced the stability and compactness of Ld ArgRS compared to other ligands. This study thus reports a unique ArgRS with respect to catalytic as well as structural properties, which can be considered a plausible drug target for the derivation of novel anti‐leishmanial agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology & Bioinformatics, School of Life Sciences, University of Hyderabad, Hyderabad, India.
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research, Hyderabad, India.
ORCID-Profile: Insaf Ahmed Qureshi
Förderung
- UoH-Institution of Eminence
Zitieren
APA
Nasim, F., Kumar, M. S., Alvala, M., & Qureshi, I. A. (2024). Unraveling the peculiarities and development of novel inhibitors of leishmanial arginyl‐tRNA synthetase. The FEBS Journal. https://doi.org/10.1111/febs.17122
Vancouver
Nasim F, Kumar MS, Alvala M, Qureshi IA. Unraveling the peculiarities and development of novel inhibitors of leishmanial arginyl‐tRNA synthetase. The FEBS Journal. 2024. doi:10.1111/febs.17122
BibTeX
@article{Nasim2024,
author = {Nasim, Fouzia and Kumar, Muppidi Shravan and Alvala, Mallika and Qureshi, Insaf Ahmed},
title = {Unraveling the peculiarities and development of novel inhibitors of leishmanial arginyl‐tRNA synthetase},
journal = {The FEBS Journal},
year = {2024},
doi = {10.1111/febs.17122}
}
EUVIMED